Brits Trim Boxing Day Budgets Amid Sales Surge
Brits slash Boxing Day budgets despite sales boom,Despite a sales boom, Brits are slashing their Boxing Day budgets. Find out why the total amount spent has fallen by 7% compared to last year.
Read More
£579 Million in Pothole Damage Breaks Records
Pothole damage hits a record high of £579 million,Find out about the rising costs of pothole damage to vehicles, which reached an all-time high of £579 million last year.
Mastering Workforce Transformation for UK SMEs
Navigating workforce changes in the UK for small businesses,Learn how to efficiently manage workforce changes as a small business owner in the UK. Stay on top of new regulations and taxes impacting payroll.
GCHQ’s Cutting‑Edge Accelerator Launches Its First Cybersecurity Start‑ups
First cyber security start-ups graduate from unique GCHQ cyber accelerator programme,Take a look at this
Huge Fine for Facebook Over WhatsApp Deal
Facebook fined a hefty sum over WhatsApp deal,How much?
The Market’s Long Wait for Clarity
Market thoughts: The wait for clarity goes on,Gain clarity on President Trump's policy stances and the impact on markets. Explore the latest market thoughts and insights.
Unleash Digital Defense: Shield London Businesses from Fraud
Why London businesses should use digital technology to protect against fraud,Find out more
Wage Growth on the Horizon: Euro Area’s 2025 Slowdown Revealed
Wage growth heading into 2025: A gradual slowdown in the Euro area,Explore the wage growth trends in the Euro area heading into 2025. Discover the gradual slowdown and regional variations.
Yen Soars on Tightening Policy Hints
Yen benefits from tighter monetary policy expectations,Discover how Japan's tighter monetary policy expectations are benefiting the yen against other major currencies.
Pharma Giant Pulls £450m UK Investment as Labour Gains Momentum
Major pharmaceutical giant cancels £450m investment in UK amid Labour’s support,Labour's failure to match the Conservative's support leads to cancellation of £450m investment by AstraZeneca in the UK.